☰

Adam L. Hartman, M.D. - Publications

Affiliations: 
Neurology Johns Hopkins University, Baltimore, MD 
Area:
Epilepsy
Tree Info Grants Similar researchers PubMed Report error

50 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Cervenka M, Pascual JM, Rho J, Thiele E, Yellen G, Whittemore V, Hartman AL. Metabolism-based therapies for epilepsy: new directions for future cures. Annals of Clinical and Translational Neurology. PMID 34247456 DOI: 10.1002/acn3.51423  0.567
2019 Berrington A, Schreck KC, Barron BJ, Blair L, Lin DDM, Hartman AL, Kossoff E, Easter L, Whitlow CT, Jung Y, Hsu FC, Cervenka MC, Blakeley JO, Barker PB, Strowd RE. Cerebral Ketones Detected by 3T MR Spectroscopy in Patients with High-Grade Glioma on an Atkins-Based Diet. Ajnr. American Journal of Neuroradiology. PMID 31649157 DOI: 10.3174/Ajnr.A6287  0.319
2019 Schreck K, Hsu F, Berrington A, Henry-Barron BJ, Blair L, Hartman A, Kossoff E, Easter L, Self M, Whitlow C, Barker P, Cervenka M, O Blakeley J, Strowd R. ACTR-44. FEASIBILITY, PHARMACODYNAMICS, AND BIOLOGIC ACTIVITY OF THE GLIOMA ATKINS-BASED DIET (GLAD) FOR PREVENTING TUMOR RECURRENCE IN GLIOMA PATIENTS Neuro-Oncology. 21: vi23-vi23. DOI: 10.1093/Neuonc/Noz175.086  0.325
2018 Dolce A, Santos P, Chen W, Hoke A, Hartman AL. Different ketogenesis strategies lead to disparate seizure outcomes. Epilepsy Research. 143: 90-97. PMID 29723773 DOI: 10.1016/J.Eplepsyres.2018.04.011  0.458
2017 Holden K, Hartman AL. d-Leucine: Evaluation in an epilepsy model. Epilepsy & Behavior : E&B. PMID 29122492 DOI: 10.1016/J.Yebeh.2017.09.003  0.417
2017 McNally MA, Hartman AL. Variability in Preferred Management of Electrographic Seizures in Neonatal Hypoxic Ischemic Encephalopathy. Pediatric Neurology. PMID 28982530 DOI: 10.1016/J.Pediatrneurol.2017.06.006  0.412
2017 Schreck KC, Berrington A, Barron BM, Blair L, Hartman A, Kossoff E, Easter L, Whitlow C, Hsu F, Cervenka MC, Blakeley JO, Barker PB, Strowd RE. NIMG-94. FEASIBILITY OF PROTON MRS FOR ASSESSING CEREBRAL METABOLIC ACTIVITY OF AN ATKINS-BASED DIET IN PATIENTS WITH GLIOMA Neuro-Oncology. 19: vi163-vi163. DOI: 10.1093/Neuonc/Nox168.663  0.306
2016 Galanopoulou AS, Wong M, Binder D, Hartman AL, Powell EM, Roopra A, Staba R, Vezzani A, Fureman B, Dingledine R. 2014 Epilepsy Benchmarks Area II: Prevent Epilepsy and Its Progression. Epilepsy Currents / American Epilepsy Society. 16: 187-91. PMID 27330451 DOI: 10.5698/1535-7511-16.3.187  0.357
2016 Hartman AL. Feed the Beast: The Power of Metabolism in Seizures. Epilepsy Currents / American Epilepsy Society. 16: 103-5. PMID 27073343 DOI: 10.5698/1535-7511-16.2.103  0.397
2016 Meoded A, Faria AV, Hartman AL, Jallo GI, Mori S, Johnston MV, Huisman TA, Poretti A. Cerebral Reorganization after Hemispherectomy: A DTI Study. Ajnr. American Journal of Neuroradiology. PMID 26767710 DOI: 10.3174/Ajnr.A4647  0.303
2015 Hartman AL, Devore CD. Rescue Medicine for Epilepsy in Education Settings. Pediatrics. PMID 26712862 DOI: 10.1542/Peds.2015-3876  0.391
2015 Knupp KG, Coryell J, Nickels KC, Ryan N, Leister E, Loddenkemper T, Grinspan Z, Hartman AL, Kossoff EH, Gaillard WD, Mytinger JR, Joshi S, Shellhaas RA, Sullivan J, Dlugos D, et al. Response To Treatment In A Prospective National Infantile Spasms Cohort. Annals of Neurology. PMID 26704170 DOI: 10.1002/Ana.24594  0.314
2015 Strowd RE, Cervenka MC, Henry BJ, Kossoff EH, Hartman AL, Blakeley JO. Glycemic modulation in neuro-oncology: experience and future directions using a modified Atkins diet for high-grade brain tumors. Neuro-Oncology Practice. 2: 127-136. PMID 26649186 DOI: 10.1093/Nop/Npv010  0.335
2015 Hartman AL. "Fold Here"-Chemical Correctors in the Treatment of Epilepsy. Epilepsy Currents / American Epilepsy Society. 15: 340-341. PMID 26633957 DOI: 10.5698/1535-7511-15.6.340  0.364
2015 Hartman AL, Santos P, O'Riordan KJ, Stafstrom CE, Marie Hardwick J. Potent anti-seizure effects of D-leucine. Neurobiology of Disease. 82: 46-53. PMID 26054437 DOI: 10.1016/J.Nbd.2015.05.013  0.409
2014 Hartman AL, Rho JM. The New Ketone Alphabet Soup: BHB, HCA, and HDAC. Epilepsy Currents / American Epilepsy Society. 14: 355-7. PMID 25678874 DOI: 10.5698/1535-7597-14.6.355  0.472
2014 Thakur KT, Probasco JC, Hocker SE, Roehl K, Henry B, Kossoff EH, Kaplan PW, Geocadin RG, Hartman AL, Venkatesan A, Cervenka MC. Ketogenic diet for adults in super-refractory status epilepticus. Neurology. 82: 665-70. PMID 24453083 DOI: 10.1212/Wnl.0000000000000151  0.312
2014 Kossoff EH, Hartman AL, Vining EP. John M. Freeman, MD (1933-2014) Neurology. 82: 1854-1855. DOI: 10.1212/Wnl.0000000000000461  0.303
2013 Hartman AL. Primum non nocere: are seizure medications safe in neonates? Epilepsy Currents / American Epilepsy Society. 13: 179-81. PMID 24009483 DOI: 10.5698/1535-7597-13.4.179  0.378
2013 Danial NN, Hartman AL, Stafstrom CE, Thio LL. How does the ketogenic diet work? Four potential mechanisms. Journal of Child Neurology. 28: 1027-33. PMID 23670253 DOI: 10.1177/0883073813487598  0.358
2013 Hartman AL, Rubenstein JE, Kossoff EH. Intermittent fasting: a "new" historical strategy for controlling seizures? Epilepsy Research. 104: 275-9. PMID 23206889 DOI: 10.1016/J.Eplepsyres.2012.10.011  0.44
2013 Hartman AL, Stafstrom CE. Harnessing the power of metabolism for seizure prevention: focus on dietary treatments. Epilepsy & Behavior : E&B. 26: 266-72. PMID 23110824 DOI: 10.1016/J.Yebeh.2012.09.019  0.44
2013 Hartman AL, Santos P, Dolce A, Hardwick JM. Rapamycin shows varied effects against seizures induced by kainic acid (i.p.). Plos One. DOI: 10.1371/Journal.Pone.0045156.G004  0.386
2013 Hartman AL, Rho JM. The Biochemical Basis of Dietary Therapies for Neurological Disorders Dietary Treatment of Epilepsy: Practical Implementation of Ketogenic Therapy. 34-44. DOI: 10.1002/9781118702772.ch5  0.474
2013 Hartman AL, Rho JM. Beyond Epilepsy: Ketogenic Diet Use in Other Disease States Dietary Treatment of Epilepsy: Practical Implementation of Ketogenic Therapy. 225-231. DOI: 10.1002/9781118702772.ch28  0.547
2012 Hartman AL, Santos P, Dolce A, Hardwick JM. The mTOR inhibitor rapamycin has limited acute anticonvulsant effects in mice. Plos One. 7: e45156. PMID 22984623 DOI: 10.1371/Journal.Pone.0045156  0.42
2012 Auvin S, Hartman AL, Desnous B, Moreau AC, Alberti C, Delanoe C, Romano A, Terrone G, Kossoff EH, Del Giudice E, Titomanlio L. Diagnosis delay in West syndrome: misdiagnosis and consequences. European Journal of Pediatrics. 171: 1695-701. PMID 22892960 DOI: 10.1007/S00431-012-1813-6  0.33
2012 Kelley SA, Hartman AL, Kossoff EH. Comorbidity of migraine in children presenting with epilepsy to a tertiary care center. Neurology. 79: 468-73. PMID 22744668 DOI: 10.1212/Wnl.0B013E3182617113  0.392
2012 Kossoff EH, Hartman AL. Ketogenic diets: new advances for metabolism-based therapies. Current Opinion in Neurology. 25: 173-8. PMID 22322415 DOI: 10.1097/Wco.0B013E3283515E4A  0.462
2012 McNally MA, Hartman AL. Ketone bodies in epilepsy. Journal of Neurochemistry. 121: 28-35. PMID 22268909 DOI: 10.1111/J.1471-4159.2012.07670.X  0.417
2012 Hartman AL. Neuroprotection in metabolism-based therapy. Epilepsy Research. 100: 286-94. PMID 21872441 DOI: 10.1016/J.Eplepsyres.2011.04.016  0.338
2012 Hartman AL, Goodkin HP. The first scientific journal dedicated to the field of Pediatric Epilepsy Journal of Pediatric Epilepsy. 1: 1. DOI: 10.3233/Pep-2012-001  0.408
2011 Kelley SA, Hartman AL. Metabolic treatments for intractable epilepsy. Seminars in Pediatric Neurology. 18: 179-85. PMID 22062942 DOI: 10.1016/J.Spen.2011.06.004  0.452
2011 Cervenka MC, Hartman AL, Venkatesan A, Geocadin RG, Kossoff EH. The ketogenic diet for medically and surgically refractory status epilepticus in the neurocritical care unit. Neurocritical Care. 15: 519-24. PMID 21523523 DOI: 10.1007/S12028-011-9546-3  0.389
2010 Muthugovindan D, Hartman AL. Pediatric epilepsy syndromes. The Neurologist. 16: 223-37. PMID 20592566 DOI: 10.1097/Nrl.0B013E3181D9D6B7  0.402
2010 Gasior M, Yankura J, Hartman AL, French A, Rogawski MA. Anticonvulsant and proconvulsant actions of 2-deoxy-D-glucose. Epilepsia. 51: 1385-94. PMID 20491877 DOI: 10.1111/J.1528-1167.2010.02593.X  0.581
2010 Hartman AL, Zheng X, Bergbower E, Kennedy M, Hardwick JM. Seizure tests distinguish intermittent fasting from the ketogenic diet. Epilepsia. 51: 1395-402. PMID 20477852 DOI: 10.1111/J.1528-1167.2010.02577.X  0.456
2009 Morrison PF, Pyzik PL, Hamdy R, Hartman AL, Kossoff EH. The influence of concurrent anticonvulsants on the efficacy of the ketogenic diet. Epilepsia. 50: 1999-2001. PMID 19389152 DOI: 10.1111/J.1528-1167.2009.02053.X  0.412
2008 Hartman AL. Does the effectiveness of the ketogenic diet in different epilepsies yield insights into its mechanisms? Epilepsia. 49: 53-6. PMID 19049588 DOI: 10.1111/J.1528-1167.2008.01835.X  0.371
2008 Barañano KW, Hartman AL. The ketogenic diet: uses in epilepsy and other neurologic illnesses. Current Treatment Options in Neurology. 10: 410-9. PMID 18990309 DOI: 10.1007/S11940-008-0043-8  0.407
2008 Gasior M, Hartman AL, Rogawski MA. The anticonvulsant activity of acetone does not depend upon its metabolites. Epilepsia. 49: 936-7. PMID 18454785 DOI: 10.1111/J.1528-1167.2007.01518_3.X  0.479
2008 Hartman AL, Lyle M, Rogawski MA, Gasior M. Efficacy of the ketogenic diet in the 6-Hz seizure test. Epilepsia. 49: 334-9. PMID 18070095 DOI: 10.1111/J.1528-1167.2007.01430.X  0.584
2007 Hartman AL, Lesser RP. Update on epilepsy and cerebral localization. Current Neurology and Neuroscience Reports. 7: 498-507. PMID 17999896 DOI: 10.1007/S11910-007-0077-4  0.31
2007 Hartman AL, Gasior M, Vining EP, Rogawski MA. The neuropharmacology of the ketogenic diet. Pediatric Neurology. 36: 281-92. PMID 17509459 DOI: 10.1016/J.Pediatrneurol.2007.02.008  0.625
2007 Gasior M, French A, Joy MT, Tang RS, Hartman AL, Rogawski MA. The anticonvulsant activity of acetone, the major ketone body in the ketogenic diet, is not dependent on its metabolites acetol, 1,2-propanediol, methylglyoxal, or pyruvic acid. Epilepsia. 48: 793-800. PMID 17386058 DOI: 10.1111/J.1528-1167.2007.01026.X  0.591
2007 Freeman JM, Kossoff EH, Hartman AL. The ketogenic diet: one decade later. Pediatrics. 119: 535-43. PMID 17332207 DOI: 10.1542/Peds.2006-2447  0.405
2007 Hartman AL, Vining EP. Clinical aspects of the ketogenic diet. Epilepsia. 48: 31-42. PMID 17241206 DOI: 10.1111/J.1528-1167.2007.00914.X  0.391
2006 Gasior M, Rogawski MA, Hartman AL. Neuroprotective and disease-modifying effects of the ketogenic diet. Behavioural Pharmacology. 17: 431-9. PMID 16940764 DOI: 10.1097/00008877-200609000-00009  0.557
2006 Hartman AL, Kossoff EH. Epilepsy surgery for the neurocutaneous disorders. Seminars in Pediatric Neurology. 13: 63-7. PMID 16818177 DOI: 10.1016/J.Spen.2006.01.012  0.353
2006 Hartman AL, Vining EPG. Febrile seizures Current Therapy in Neurologic Disease. 25-29. DOI: 10.1016/B9780323034326.500106  0.311
Show low-probability matches.